X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (20) 20
humans (19) 19
adult (15) 15
female (13) 13
male (13) 13
middle aged (13) 13
index medicus (12) 12
transplantation (11) 11
aged (10) 10
oncology (9) 9
treatment outcome (8) 8
chemotherapy (7) 7
adolescent (6) 6
leukemia (6) 6
stem cells (6) 6
antineoplastic agents - therapeutic use (5) 5
cyclophosphamide (5) 5
hematology, oncology and palliative medicine (5) 5
hemic and lymphatic diseases (5) 5
risk factors (5) 5
stem cell transplantation (5) 5
acute myeloid-leukemia (4) 4
aged, 80 and over (4) 4
busulfan (4) 4
health aspects (4) 4
hematopoietic stem cell transplantation - adverse effects (4) 4
lymphoma (4) 4
lymphomas (4) 4
patients (4) 4
survival analysis (4) 4
acute disease (3) 3
acute myelogenous leukemia (3) 3
bone-marrow transplantation (3) 3
bone-marrow-transplantation (3) 3
busulfan - administration & dosage (3) 3
care and treatment (3) 3
case report (3) 3
cytokines (3) 3
diagnosis (3) 3
disease (3) 3
disease-free survival (3) 3
drug design (3) 3
hematologic malignancies (3) 3
hematopoietic stem cell transplantation (3) 3
hematopoietic stem cell transplantation - mortality (3) 3
hematopoietic stem cells (3) 3
mortality (3) 3
multiple myeloma (3) 3
myelodysplastic syndrome (3) 3
non-hodgkin lymphoma (3) 3
survival (3) 3
survival rate (3) 3
therapy (3) 3
transplantation, homologous (3) 3
young adult (3) 3
abridged index medicus (2) 2
aml (2) 2
analysis (2) 2
antibody drug conjugates (2) 2
antineoplastic agents - chemistry (2) 2
antineoplastic agents - immunology (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis - drug effects (2) 2
article (2) 2
article subject (2) 2
autografts (2) 2
autologous stem cell transplantation (2) 2
b-cell lymphoma (2) 2
blood diseases (2) 2
bone marrow (2) 2
bone marrow transplantation - adverse effects (2) 2
bone marrow transplantation - mortality (2) 2
bone-marrow (2) 2
busulfan - pharmacokinetics (2) 2
cancer therapies (2) 2
cd19 antigen (2) 2
chemistry, pharmaceutical - methods (2) 2
chemistry, pharmaceutical - trends (2) 2
child (2) 2
chronic disease (2) 2
chronic myelogenous leukemia (2) 2
clinical trials as topic (2) 2
comparative analysis (2) 2
drug dosages (2) 2
eosinophilia (2) 2
fludarabine (2) 2
genes (2) 2
genetic aspects (2) 2
graft vs host disease - diagnosis (2) 2
graft vs host disease - etiology (2) 2
graft vs host disease - mortality (2) 2
graft vs host disease - prevention & control (2) 2
granulocyte colony-stimulating factor - administration & dosage (2) 2
hematologic neoplasms - therapy (2) 2
hemopoiesis (2) 2
high-dose chemotherapy (2) 2
hodgkin lymphoma (2) 2
hypereosinophilic syndrome (2) 2
immunoconjugates - chemistry (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 26, pp. 2531 - 2544
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2019, Volume 20, Issue 1, pp. 31 - 42
Axicabtagene ciloleucel is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. In the previous analysis of the ZUMA-1 registrational study,... 
2-YEAR SURVIVORS | HODGKIN | CHIMERIC ANTIGEN RECEPTOR | OUTCOMES | ONCOLOGY | TRANSPLANTATION | Analysis | Lymphomas
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. 1047 - 1051
Journal Article
Oncotarget, ISSN 1949-2553, 2013, Volume 4, Issue 3, pp. 397 - 412
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 5743 - 5743
Abstract Introduction: Bortezomib (Velcade¨; V), a proteasome inhibitor, is currently FDA (Food and Drug Administration) approved for the treatment of multiple... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e18557 - e18557
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 5442 - 5442
Abstract Introduction Interactions between bone marrow stromal cells and hematopoietic stem cells (HSC) that allow mobilization and subsequent peripheral blood... 
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, p. S390
ATLL is an aggressive T cell malignancy with dismal prognosis which occurs mainly in Caribbean immigrants in the US. AlloSCT is an effective treatment option... 
Leukemia | Mortality | Stem cells | Lymphomas | Medically uninsured persons | Transplantation | T cells | Health aspects
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1685 - 1685
Abstract Introduction: Adult T-cell leukemia/lymphoma (ATLL) is a rare mature T-cell malignancy associated with human T-lymphotropic virus type 1 (HTLV-1)... 
Journal Article
Case reports in oncological medicine, ISSN 2090-6706, 2018, Volume 2018, pp. 5382852 - 6
SOS is a rare complication of stem cell transplantation and has significant morbidity and mortality. We present three cases of SOS and highlight underlying... 
Cyclophosphamide | Kidney failure | Mortality | Stem cells | Transplantation | Metronidazole | Drug approval | Sulbactam | Risk factors | Liver diseases | Transplants & implants | Hematology | Leukemia | Multiple myeloma | Infections | Patients | Cancer therapies | Chemotherapy | Biopsy | Drug dosages
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.